KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Other financing activities: 2017-2023

Historic Other financing activities for Aquestive Therapeutics (AQST) over the last 5 years, with Dec 2023 value amounting to $4.6 million.

  • Aquestive Therapeutics' Other financing activities fell 12.50% to $7,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3,000, marking a year-over-year increase of 100.04%. This contributed to the annual value of $4.6 million for FY2023, which is N/A change from last year.
  • According to the latest figures from FY2023, Aquestive Therapeutics' Other financing activities is $4.6 million, which was up 59.61% from $2.9 million recorded in FY2020.
  • In the past 5 years, Aquestive Therapeutics' Other financing activities ranged from a high of $4.6 million in FY2023 and a low of $2.9 million during FY2020.
  • In the last 1 years, Aquestive Therapeutics' Other financing activities had a median value of $4.6 million in 2023 and averaged $4.6 million.
  • Data for Aquestive Therapeutics' Other financing activities shows a maximum YoY fell of 26.28% (in 2020) over the last 5 years.
  • Aquestive Therapeutics' Other financing activities (Yearly) stood at $3.9 million in 2019, then declined by 26.28% to $2.9 million in 2020, then reached $4.6 million in 2023.